PTC Misses Phase III In Friedrich Ataxia, But Isn’t Giving Up

Company Ends Gene Therapy R&D, Cuts Headcount

 
• By Joseph Haas
PTC
PTC maintains hopes in FA, exits gene therapy R&D • Source: Shutterstock

More from Strategy

More from Business